Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJSE:920504's EV-to-FCF is ranked worse than 87.29% of 409
companies
in the Medical Devices & Instruments industry
Industry Median: 24.41
vs BJSE:920504: 112.48
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Boxun Medical Biological Instrument (BJSE:920504) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Boxun Medical Biological Instrument's PE Ratio (TTM) for today is calculated as:
Shanghai Boxun Medical Biological Instrument's share price for today is ¥17.80.
Shanghai Boxun Medical Biological Instrument's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.340.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shanghai Boxun Medical Biological Instrument EV-to-FCF Related Terms
Shanghai Boxun Medical Biological Instrument EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Boxun Medical Biological Instrument EV-to-FCF Chart
Shanghai Boxun Medical Biological Instrument Annual Data
BJSE:920504 vs ISRG, BDX, MDLN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, Shanghai Boxun Medical Biological Instrument's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Boxun Medical Biological Instrument EV-to-FCF vs Medical Devices & Instruments Industry
Shanghai Boxun Medical Biological Instrument's current Enterprise Value is ¥696.2 Mil.
Shanghai Boxun Medical Biological Instrument's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Boxun Medical Biological Instrument (BJSE:920504) has a EV-to-FCF of 115.35 as of Aug. 15, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. This is 385% above median its historical median of 23.78. According to the industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #357 out of 409 companies in the Medical Devices & Instruments industry, placing it in the top 87.3%.
Is Shanghai Boxun Medical Biological Instrument's EV-to-FCF too high?
Shanghai Boxun Medical Biological Instrument's current EV-to-FCF of 115.35 is 385% above median its 10-year median of 23.78. The Medical Devices & Instruments industry median EV-to-FCF is 24.41. Shanghai Boxun Medical Biological Instrument's value of 115.35 is 372.6% above this industry median. Based on the distribution chart, Shanghai Boxun Medical Biological Instrument ranks #357 out of 409 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shanghai Boxun Medical Biological Instrument has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Boxun Medical Biological Instrument's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #357 out of 409 companies for EV-to-FCF. This places Shanghai Boxun Medical Biological Instrument in the lower half of its industry. The industry median EV-to-FCF is 24.41. Shanghai Boxun Medical Biological Instrument's value of 115.35 is 372.6% above this benchmark. While the company's 10-year median is 23.78 vs. the industry median of 24.41, Shanghai Boxun Medical Biological Instrument has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 24.41, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Boxun Medical Biological Instrument's current EV-to-FCF of 115.35 is 372.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 24.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Boxun Medical Biological Instrument's current EV-to-FCF is 115.35, which is 385% above median its own 10-year median of 23.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Boxun Medical Biological Instrument stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument (BJSE:920504) is currently considered Fairly Valued. The stock's GF Value™ is ¥19.41, compared to a current price of ¥17.80 — trading 8.3% below its estimated fair value. The current EV-to-FCF is 115.35, which is 385% above median its 10-year median of 23.78 and 372.6% above the Medical Devices & Instruments industry median of 24.41. Shanghai Boxun Medical Biological Instrument's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shanghai Boxun Medical Biological Instrument (BJSE:920504), the current EV-to-FCF is 115.35 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Boxun Medical Biological Instrument (BJSE:920504) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument stock appears to be undervalued.
The current stock price of ¥17.80 is trading 8.3% below its estimated GF Value™ of ¥19.41.
GuruFocus considers Shanghai Boxun Medical Biological Instrument to be Fairly Valued.
Key valuation signals for BJSE:920504:
EV-to-FCF: 115.35 (385% above median its 10-year median of 23.78)
GF Value™: ¥19.41 vs. price of ¥17.80 (8.3% below fair value)
Industry Position: 372.6% above the Medical Devices & Instruments median (#357 of 409)
No single metric tells the full story. See the BJSE:920504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Boxun Medical Biological Instrument Corp is engaged in Research and development, production, sales, and service of laboratory equipment and life science instruments. The company's main products are temperature and humidity control series products, high-pressure sterilization series products, and purification safety series products, etc.
69GF Score
Get the complete analysis for BJSE:920504
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920504 has been successfully added to your 
